Persistent High Non-High-Density Lipoprotein Cholesterol in Early Childhood: A Latent Class Growth Model Analysis

Jordan M Albaum1, Sarah Carsley2, Yang Chen3

  • 1Pediatrics Outcomes Research Team (PORT), The Hospital for Sick Children, Toronto, Ontario; Faculty of Medicine, University of Toronto, Toronto, Ontario; Child Health Evaluative Sciences, The Hospital for Sick Children Research Institute, Toronto, Ontario.

The Journal of Pediatrics
|November 28, 2017
PubMed

Insights

Persistent high non-HDL cholesterol in children is linked to family history. Early identification and intervention are key for cardiovascular health in kids.

Area of Science:

  • Pediatric lipidology
  • Cardiovascular risk assessment in children
  • Public health and preventive medicine

Background:

  • Non-high-density lipoprotein (HDL) cholesterol patterns in early childhood are not well understood.
  • Identifying children with persistent high non-HDL cholesterol is crucial for early cardiovascular disease prevention.
  • Understanding associated factors can guide targeted interventions.

Purpose of the Study:

  • To analyze non-HDL cholesterol trajectories in healthy urban children from infancy.
  • To identify risk factors associated with persistent high non-HDL cholesterol levels.
  • To inform the development of early childhood lipid screening tools.

Main Methods:

  • Latent class growth modeling was used to identify non-HDL cholesterol trajectories in 608 children from the TARGet Kids! network.
  • Children were categorized into normal or persistent-high non-HDL cholesterol groups based on guideline cut-offs.
  • Logistic regression examined associations between trajectory groups and anthropometric/cardiometabolic risk factors.

Main Results:

  • Four distinct non-HDL cholesterol trajectory groups were identified; 2 (n=157) showed persistent high levels.
  • Family history of high cholesterol significantly increased the odds of persistent high non-HDL cholesterol (OR 2.04).
  • East/Southeast Asian ethnicity, longer breastfeeding, and higher birth weight were associated with lower odds of persistent high non-HDL cholesterol.

Conclusions:

  • Family history is a strong predictor of persistent high non-HDL cholesterol in early childhood.
  • Early identification of children at risk for high lipids is essential for cardiovascular health.
  • Development of a clinical prediction tool for childhood lipids could facilitate timely interventions.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
653
Lipid Absorption01:24

Lipid Absorption

Dietary triglycerides from chyme in the duodenum are mixed with bile salts produced by the liver to emulsify fats. As a result, large droplets are broken down into smaller ones, increasing the surface area for enzymatic action. Once emulsified, pancreatic lipases hydrolyze the triglycerides into free fatty acids and monoglycerides.
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
2.9K
Longitudinal Studies01:26

Longitudinal Studies

Longitudinal studies are also widely used in other medical and social science fields. For instance, in cardiovascular research, they can monitor patients' health over decades to identify risk factors for heart disease, such as high cholesterol or smoking, and evaluate the long-term effectiveness of preventive measures. Similarly, in mental health studies, researchers might follow individuals from adolescence into adulthood to understand the development and progression of conditions like...
548
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
257